ArticleThe Korean journal of internal medicine2018

Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea.

Osung Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.